Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
US
National Institutes of Health
grant
open
#grants-gov-RFA-NS-26-001
Response due Nov 10, 2026 · 00:00 UTC
Re-run AI extraction
Auto-enrichment did not complete. Trigger it manually — 10–20 seconds.
